WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Tuesday reported a loss of $28.9 million in its fourth quarter.On a per-share basis, the Warren, New Jersey-based company said it had a loss of 72 cents. Losses, adjusted to extinguish debt, came to 38 cents per share.The specialty pharmaceutical company posted revenue of $11.1 million in the period.For the year, the company reported that its loss widened to $70.5 million, or $1.85 per share. Revenue was reported as $50.8 million.Aquestive Therapeutics expects full-year revenue in the range of $42 million to $47 million.In the final minutes of trading on Tuesday, the companyâ€™s shares hit $2.82. A year ago, they were trading at $4.26._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST